As a non-profit association which brings together industry and academic stakeholders, the PRI employs a collaborative approach to developing and sharing Regulatory Science expertise for the development of microbiome-based medicinal products.
Like Enterosys, the PRI believes that the microbiome is the future of human medicine. Our company contributes with the other members in technical and collaboration efforts of the microbiome & human health space.